| Sherilyn Bermudez Diomampo, | |
|
2000 E Greenville St, Suite 5130, Anderson, SC 29621-1580 | |
| (864) 512-4590 | |
| (864) 512-4595 |
| Full Name | Sherilyn Bermudez Diomampo |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 16 Years |
| Location | 2000 E Greenville St, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225382336 | NPI | - | NPPES |
| 400925 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 40092 (South Carolina) | Primary |
| 207RR0500X | Internal Medicine - Rheumatology | 57.020115 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anmed Health | Anderson, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anmed Health | 1951215243 | 276 |
News Archive
The resignation of CMS Administrator Mark McClellan will provide him with "a golden opportunity" to "tell us what to do about Medicare," the "monster of our future," columnist Robert Samuelson writes in a Washington Post opinion piece.
EntreMed, Inc., today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor. The clinical data were published in the December 3, 2010 on-line issue of the American Association for Cancer Research journal, Clinical Cancer Research, and are expected to appear soon in the print version of the publication.
Device management using a home monitoring system with daily telemetry in patients with ICDs is a safe alternative to conventional monitoring and could decrease the number of inappropriate shocks, according to results of the ECOST study, a multicentre randomised trial performed in France.
An expanding population of bacterial strains that are drug resistant, including methicillin-resistant Staphylococcus aureus (MRSA), will be the most important justification for nucleic acid-based tests (NAT).
The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.
› Verified 6 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
The resignation of CMS Administrator Mark McClellan will provide him with "a golden opportunity" to "tell us what to do about Medicare," the "monster of our future," columnist Robert Samuelson writes in a Washington Post opinion piece.
EntreMed, Inc., today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor. The clinical data were published in the December 3, 2010 on-line issue of the American Association for Cancer Research journal, Clinical Cancer Research, and are expected to appear soon in the print version of the publication.
Device management using a home monitoring system with daily telemetry in patients with ICDs is a safe alternative to conventional monitoring and could decrease the number of inappropriate shocks, according to results of the ECOST study, a multicentre randomised trial performed in France.
An expanding population of bacterial strains that are drug resistant, including methicillin-resistant Staphylococcus aureus (MRSA), will be the most important justification for nucleic acid-based tests (NAT).
The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sherilyn Bermudez Diomampo, Po Box 100147, Columbia, SC 29202-3147 Ph: (864) 512-4590 | Sherilyn Bermudez Diomampo, 2000 E Greenville St, Suite 5130, Anderson, SC 29621-1580 Ph: (864) 512-4590 |
News Archive
The resignation of CMS Administrator Mark McClellan will provide him with "a golden opportunity" to "tell us what to do about Medicare," the "monster of our future," columnist Robert Samuelson writes in a Washington Post opinion piece.
EntreMed, Inc., today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor. The clinical data were published in the December 3, 2010 on-line issue of the American Association for Cancer Research journal, Clinical Cancer Research, and are expected to appear soon in the print version of the publication.
Device management using a home monitoring system with daily telemetry in patients with ICDs is a safe alternative to conventional monitoring and could decrease the number of inappropriate shocks, according to results of the ECOST study, a multicentre randomised trial performed in France.
An expanding population of bacterial strains that are drug resistant, including methicillin-resistant Staphylococcus aureus (MRSA), will be the most important justification for nucleic acid-based tests (NAT).
The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.
› Verified 6 days ago
Shahzad H Sheikh, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-5849 Fax: 864-512-7575 | |
Winston Cordell Floyd, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 400 North Fant Street, Suite G, Anderson, SC 29621 Phone: 864-224-2197 Fax: 864-225-0033 | |
David W Potts, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-3915 Fax: 864-260-3920 | |
Sanjeev Kumar, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 819 N Fant St, Anderson, SC 29621 Phone: 864-261-1800 Fax: 864-261-1856 | |
Rajeev Malik, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Ste 5000, Anderson, SC 29621 Phone: 864-224-5765 Fax: 864-224-1449 | |
Daniel W. Grisham Sr., M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St Ste 2300, Anderson, SC 29621 Phone: 864-512-5780 Fax: 864-375-1155 | |
Dr. William Muirhead Turner, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 131 Addis Cir, Anderson, SC 29626 Phone: 864-934-6833 |